HCW Biologics Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
1.84M
on 2026-08-14, from 288K on 2025-05-13 10-Q/A ↗
Earlier counts are adjusted for the 1-for-5 reverse split; each bar's tip shows the count as filed.
Counts before 2025-05-13 are left out: the count went from 8.99M on 2025-03-25 to 288K on 2025-05-13, a change no split on file explains.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
15 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-14 is not read yet.
Cash
0.2 quarters
$741K on 2026-06-30 ÷ $3.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-05-21 | Private placement incl. 2.85M pre-funded | 3,274,021 | $1.28 | $4.0M | 8-K ↗ |
| 2026-02-17 | Public offering | 2,477,292 | $0.6055 | $1.5M | 424B4 ↗ |
Also on file: a 1-for-5 reverse split, 2026-06-24 8-K ↗